CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company
TENAX THERAPEUTICS, INC.
Sign in to watch- Ticker
- TENX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262593535
- Phone
- 919-855-2100
- Business address
- 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
- Former names
- OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
- Open-market buys, last 90 days
- $6,396,312
- in 7 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$6,396,312. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 73 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-08 | Davidson Michael H. Director | Purchase | +2,500 | 2,881 | ||
| 2024-08-08 | Davidson Michael H. Director | Purchase · Pre-Funded Warrant | +47,500 | 47,500 | ||
| 2024-08-08 | Davidson Michael H. Director | Purchase · Warrant | +25,000 | 25,000 | ||
| 2024-05-17 | Rich Stuart Chief Medical Officer | Grant or award · Stock Option (right to buy) | +119 | 119 | ||
| 2024-05-17 | Giordano Christopher Thomas CEO | Grant or award · Stock Option (right to buy) | +437 | 437 | ||
| 2022-09-21 | Rich Stuart Chief Medical Officer | Gift | −1,909,585 | 424,347 | ||
| 2022-09-21 | Rich Stuart Chief Medical Officer | Gift | +1,909,585 | 1,909,585 | ||
| 2022-08-11 | Doogan Declan Director | Gift | −567,871 | 0 | ||
| 2022-08-11 | Doogan Declan Director | Gift | +567,871 | 3,637,871 | ||
| 2022-06-09 | Rich Stuart Chief Medical Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2022-06-09 | PROEHL GERALD T Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2022-06-09 | Hunter Robyn Director | Grant or award · Stock Option (right to buy) | +6,250 | 6,250 | ||
| 2022-06-09 | Giordano Christopher Thomas CEO | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2022-06-09 | Doogan Declan Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2022-06-09 | Davidson Michael H. Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2022-06-09 | Almenoff June Sherie Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2022-05-18 | ARMISTICE CAPITAL, LLC Director | Returned to the company · Warrant (right to buy) | −4,773,269 | 0 | ||
| 2022-05-18 | ARMISTICE CAPITAL, LLC Director | Grant or award · Warrant (right to buy) | +4,773,269 | 4,773,269 | ||
| 2022-05-18 | ARMISTICE CAPITAL, LLC Director | Returned to the company · Series B Common Stock Purchase Warrants | −3,175,924 | 0 | ||
| 2022-05-18 | ARMISTICE CAPITAL, LLC Director | Grant or award · Series B Common Stock Purchase Warrants | +3,175,924 | 3,175,924 |
Page 4 of 9 · 172 trades